HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous metoprolol and cardiac dysrhythmias. An evaluation in the management of dysrhythmias in outpatient dental anaesthesia.

Abstract
The use of intravenous metoprolol in a dose of 0.06--0.17 mg/kg body weight proved effective in the treatment of sinus tachycardia in excess of 150 beats/min and/or ventricular dysrhythmias associated with light halothane anaesthesia for outpatient dental surgery. There were no side-effects related to this cardioselective beta-blocker in the dosage used. The prophylactic use of oral metoprolol should be considered for patients who find the prospect of dental treatment a fearsome experience.
AuthorsW N Rollason, J G Russell
JournalAnaesthesia (Anaesthesia) Vol. 35 Issue 8 Pg. 783-9 (Aug 1980) ISSN: 0003-2409 [Print] England
PMID7446917 (Publication Type: Journal Article)
Chemical References
  • Propanolamines
  • Metoprolol
Topics
  • Adolescent
  • Adult
  • Aged
  • Ambulatory Surgical Procedures
  • Anesthesia, Dental (adverse effects)
  • Anesthesia, General (adverse effects)
  • Arrhythmias, Cardiac (drug therapy, etiology)
  • Drug Evaluation
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Metoprolol (administration & dosage, therapeutic use)
  • Middle Aged
  • Propanolamines (therapeutic use)
  • Tachycardia (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: